IBOC International posts Q4 2025 EPS beat and mild YoY revenue growth shares tick higher on positive investor response REPL Replimune Group beats Q1 2026 EPS estimates shares drop three percent amid zero quarterly revenue CLS Celestica reports Q4 2025 earnings above estimates as year over year revenue rises 285 percent with modest intraday share gains Best Time to Sell Crane NXT CXT Stock Slow Drop 20260420 Why MYR Group MYRG looks attractive at current levels Sinks 20260508 OWLS OBOOK Q1 results show continued losses but modest 39 revenue growth shares edge up despite challenges ATHR Aether shares surge 487 as EPS beat exceeds expectations despite revenue decline and quarterly loss The Simply SMPL Jumps 121 on Strong Momentum 20260518 Assured Guar AGO Q1 2026 Earnings Why the Beat Matters Strand Life Sciences Advances Drug Discovery with UltraMiniaturized Protein Biomarker Platform FTRE Q1 2026 Earnings Massive EPS Beat Overshadowed by Market Skepticism Actuate ACTU Surges 458 Nearing 264 Resistance 20260520 Tonix TNXP Stock Up 660 Key Resistance at 1535 20260520 Cogent Communications CCOI Plunges 1145 Network Stock Tests Key Support Bank of Baroda Derivatives Contracts See Adjustment MarktoMarket Settlement Price as Reference Rate CANF Q4 2023 Earnings Narrowed Loss Significantly Beats Estimates Stock Slightly Down LUNR Shares Fluctuate Following NASA Contract Awards to Competitors